Quarterly Activities/Appendix 5B Cash Flow Report
| Stock | Neurizer Ltd (NRZ.ASX) |
|---|---|
| Release Time | 4 May 2026, 10:03 a.m. |
| Price Sensitive | Yes |
Quarterly Activities/Appendix 5B Cash Flow Report
- Two Letters of Award awarded by Reliance Industry Group for IP licensing and sale of Demonstration Plant
- Shares continue to be suspended from trading on ASX, company working to resolve issues
- Stage 1 of NeuRizer Urea Project progressing, including submission of EIS and ongoing monitoring activities
NeuRizer Ltd ('NeuRizer' or the 'Company') has submitted its Quarterly Activities Report and Quarterly Cash Flow Statement for the quarter ending 31st of March 2026. The key highlights include the announcement of two Letters of Award (LOA's) awarded to NRZ by Reliance Industry Group (RIL) for IP licensing and the sale of the Demonstration Plant, with payment commencing in April 2026. The company also hosted representatives of RIL's engineering team and consultants at Leigh Creek to inspect and obtain a thorough understanding of the demonstration plant. The company's shares continue to be suspended from trading under the Australian Securities Exchange (ASX) Listing Rule 17.5, and NeuRizer continues to work with its Auditor and the ASX to resolve the remaining issues giving rise to the suspension. Stage 1 of the NeuRizer Urea Project (NRUP) continues to build on the successful Pre-Commercial Demonstration that NeuRizer operated in 2018 and 2019, with the company progressing the Stage 1 EIS and submitting it in May 2026. Water monitoring activities are also continuing, and the project remains a declared Major Project for South Australia.
The company is now funded to continue its operations for the next 2 quarters, with ongoing monthly payments for the next 15 months allowing the Company to progress with its business objectives.